| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/23/2003 | CA2503681A1 Method for isolating and measuring proliferation of long-term label retaining cells and stem cells |
| 10/23/2003 | CA2484681A1 Human papilloma virus detection with dna microarray |
| 10/23/2003 | CA2483451A1 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance |
| 10/23/2003 | CA2482915A1 Endocrine cell lines and method of using the same |
| 10/23/2003 | CA2482904A1 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification |
| 10/23/2003 | CA2482903A1 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
| 10/23/2003 | CA2482849A1 Method, system and kit for detecting an analyte in a sample |
| 10/23/2003 | CA2482841A1 Method of measuring human cyp3a inducibility |
| 10/23/2003 | CA2482824A1 Method for the identification of modulators of a secretase activity |
| 10/23/2003 | CA2482716A1 Method of forming pancreatic .beta. cells from mesenchymal cells |
| 10/23/2003 | CA2482692A1 Method of analyzing molecule and molecule analyzer |
| 10/23/2003 | CA2482658A1 Compositions, methods and kits for immunochemical determination of mannan-binding lectin (mbl) |
| 10/23/2003 | CA2482634A1 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction |
| 10/23/2003 | CA2482612A1 Use of substances for treatment of tumors |
| 10/23/2003 | CA2482317A1 Haptoglobin fragments diagnostic of alzheimers disease |
| 10/23/2003 | CA2482313A1 Heterocyclic compounds |
| 10/23/2003 | CA2482293A1 Method of nondestructive examination of chromium-containing nickel-based alloy for grain boundary corrosion and examination apparatus |
| 10/23/2003 | CA2482244A1 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis |
| 10/23/2003 | CA2482129A1 Methods for determining levels of human b-type natriuretic peptide precursors |
| 10/23/2003 | CA2482126A1 Luminescent markers |
| 10/23/2003 | CA2481905A1 Mutation detection and identification |
| 10/23/2003 | CA2481895A1 Methods and reagents for assaying protein kinase activity |
| 10/23/2003 | CA2481827A1 Polyvalent cation-sensing receptor in atlantic salmon |
| 10/23/2003 | CA2481632A1 Method of detecting an analyte in a fluid |
| 10/23/2003 | CA2481545A1 Immunoassay probe |
| 10/23/2003 | CA2481509A1 Her-2 receptor tyrosine kinase molecules and uses thereof |
| 10/23/2003 | CA2481508A1 G-protein coupled receptor ligands and methods |
| 10/23/2003 | CA2481503A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 10/23/2003 | CA2481501A1 Monitoring blood substances using self-sampled tears |
| 10/23/2003 | CA2481478A1 Stimulation of nerve cell regeneration |
| 10/23/2003 | CA2481420A1 Method for cleaving and deglycosylating antibodies to promote ligand binding |
| 10/23/2003 | CA2481387A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
| 10/23/2003 | CA2481378A1 A sample surface component for an instrument that measures viscosity and viscoelasticity |
| 10/23/2003 | CA2481358A1 Method for making a molecularly smooth surface |
| 10/23/2003 | CA2481355A1 Hydrophobic zone device |
| 10/23/2003 | CA2481349A1 Peptides for detection of antibody to a. phagocytophilum |
| 10/23/2003 | CA2481328A1 Monomeric and dimeric fluorescent protein variants and methods for making same |
| 10/23/2003 | CA2481231A1 Colon tumor specific binding peptides |
| 10/23/2003 | CA2481186A1 Attenuated gram negative bacteria |
| 10/23/2003 | CA2481087A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 10/23/2003 | CA2481051A1 Multi-parameter assays including analysis discs and methods relating thereto |
| 10/23/2003 | CA2481042A1 Mycoplasma polypeptides |
| 10/23/2003 | CA2480990A1 Methods and devices for performing chemical reactions on a solid support |
| 10/23/2003 | CA2480986A1 Process control based on microbiological activity |
| 10/23/2003 | CA2480836A1 Method for characterising analytes |
| 10/23/2003 | CA2480775A1 Immunostimulatory g,u-containing oligoribonucleotides |
| 10/23/2003 | CA2480745A1 Methods for treating tweak-related conditions |
| 10/23/2003 | CA2480665A1 Use of na,k-atpase a-and b-subunits in bladder cancer detection and drug screening |
| 10/23/2003 | CA2480491A1 High-density lipoprotein assay device and method |
| 10/23/2003 | CA2480202A1 System and method for data analysis, manipulation, and visualization |
| 10/23/2003 | CA2479835A1 An ephrin-b receptor protein involved in carcinoma |
| 10/23/2003 | CA2479818A1 System and method for integrated computer-aided molecular discovery |
| 10/23/2003 | CA2478398A1 Methods for identifying compounds that modulate enzymatic activity |
| 10/23/2003 | CA2478395A1 Methods for identifying allosteric sites |
| 10/22/2003 | EP1355256A2 Computer method and devices for biomolecule analysis |
| 10/22/2003 | EP1355159A1 Use of fragments of carbamyl phosphate synthetase I (CPS 1) for the diagnosis of inflammatory diseases and sepsis |
| 10/22/2003 | EP1355158A1 Method for diagnosing inflammatory and infectious diseases by detecting the phosphoprotein LASP-1 as inflammation marker |
| 10/22/2003 | EP1355157A1 FADD proteins, phosphorylated p38-MAPK and FasL as tumours markers |
| 10/22/2003 | EP1355155A1 Combinational biosensor |
| 10/22/2003 | EP1355154A2 Accelerator for agglutination reactions, reagent for biochemical assays, and biochemical assay method |
| 10/22/2003 | EP1355153A1 Screening method for agents against cardiovascular diseases |
| 10/22/2003 | EP1355152A1 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen |
| 10/22/2003 | EP1355149A2 Assessing colorectal cancer |
| 10/22/2003 | EP1355148A1 Method to assess the presence of defects, such as cracks or bevelled edges, on the surface of wooden boards |
| 10/22/2003 | EP1355147A2 Probe for measuring the alcohol content in liquids |
| 10/22/2003 | EP1355146A2 Use of the multipin platform as anchor device |
| 10/22/2003 | EP1355145A1 A method for analysing metals in the fundamental state utilizing the statistical distribution of elements |
| 10/22/2003 | EP1354962A1 Use of the slug gene or of the transcription or expression products thereof in the detection and/or treatment of cancerous cells |
| 10/22/2003 | EP1354961A1 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 10/22/2003 | EP1354951A1 Method of examining ability to control nerve cell plasticity |
| 10/22/2003 | EP1354949A1 Human fgf23 protein mutant lowering blood phosphorus level |
| 10/22/2003 | EP1354946A1 Bhlh-pas proteins, genes thereof and utilization of the same |
| 10/22/2003 | EP1354945A1 Method of identifying within a mammala dna encoding physiologically active polypeptide |
| 10/22/2003 | EP1354943A2 Monoclonal antibodies, hybridomas, cell isolation method, isolated cells and immunological diagnostic method |
| 10/22/2003 | EP1354892A1 Peptides capable of inducing attraction of the axonal growth and their use for treating neurodegenerative diseases |
| 10/22/2003 | EP1354890A1 Novel polypeptide and dna thereof |
| 10/22/2003 | EP1354889A1 Trasncription activation complex and utilization thereof |
| 10/22/2003 | EP1354210A1 Method for cancer diagnostics |
| 10/22/2003 | EP1354209A2 Method for identifying compounds to treat medical pathologies associated with molecular crystallization |
| 10/22/2003 | EP1354208A2 Methods of diagnosis and treatment of osteoporosis |
| 10/22/2003 | EP1354206A2 Standard diluent for multiplex assays |
| 10/22/2003 | EP1354205A2 Methods and agents for detecting the probability of the future occurrence or progression of diseases that are associated with a disorder of the no metabolism |
| 10/22/2003 | EP1354204A2 Hcv antigen/antibody combination assay |
| 10/22/2003 | EP1354203A2 Biomarkers of transitional cell carcinoma of the bladder |
| 10/22/2003 | EP1354202A1 Method for detecting pancreatic and gastro-intestinal illnesses |
| 10/22/2003 | EP1354201A2 Peptide biosensors for anthrax protease |
| 10/22/2003 | EP1354200A2 Method of screening for gpr40 ligands |
| 10/22/2003 | EP1354199A2 Diagnosis and treatment of multiple sclerosis |
| 10/22/2003 | EP1354198A2 Method for the analysis of soluble analytes |
| 10/22/2003 | EP1354197A1 Surface chemical modification of optical elements |
| 10/22/2003 | EP1354196A2 Diagnostics, drug screening and treatment for cancer |
| 10/22/2003 | EP1354195A2 SYSTEM AND METHOD FOR i IN VITRO /i ANALYSIS OF THERAPEUTIC AGENTS |
| 10/22/2003 | EP1354194A2 Device and method for analyzing fat of meat |
| 10/22/2003 | EP1354191A2 Oxygen monitoring apparatus and methods of using the apparatus |
| 10/22/2003 | EP1354189A2 Rapid test for biological substances using ftir |
| 10/22/2003 | EP1354188A2 Apparatus for the detection and measurement of particulates in molten metal |
| 10/22/2003 | EP1354186A2 Lateral flow testing device with on-board chemical reactant |
| 10/22/2003 | EP1354184A2 A method of wear testing a tire |
| 10/22/2003 | EP1354079A2 Methods of searching for solid forms and screening a sample according to its forms |
| 10/22/2003 | EP1354062A2 Target activated nucleic acid biosensor and methods of using same |